| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $29.9M | +22.1% |
| Cost of Revenue | $7.2M | +17.9% |
| Gross Profit | $22.7M | +23.5% |
| R&D Expense | $6.1M | +14.7% |
| SG&A Expense | $13.4M | -4.2% |
| Operating Income | -$10.4M | +32.8% |
| Net Income | -$10.4M | +26.6% |
| EPS (Basic) | -$0.91 | +29.5% |
| EPS (Diluted) | -$0.91 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -63.6% |
| Accounts Receivable | $5.4M | +2.0% |
| Current Assets | $13.0M | -47.8% |
| Total Assets | $24.4M | -16.7% |
| Current Liabilities | $11.1M | -1.4% |
| Long-term Debt | $2.0M | — |
| Total Liabilities | $13.8M | +18.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | -0.4% |
| Capital Expenditures | $72K | -12.2% |
| Investing Cash Flow | -$5.7M | -253.0% |
| Financing Cash Flow | -$1.3M | -108.1% |
| Free Cash Flow | -$5.1M | -0.2% |
| +29.5% |
| Stockholders' Equity |
| $10.6M |
| -39.8% |